Sign in

NCT06523387Recruiting

Online Pivotal Response Treatment Training in Autism Spectrum Disorder

Randomized Controlled Trial of an Online Pivotal Response Treatment Training in Autism Spectrum Disorder

Source: ClinicalTrials.gov · Last updated 19 May 2026

Brief summary (registry, in English)

This is a research study that will assess the effects of a Pivotal Response Treatment Online Training Course (PRT-O) for training parents of children with Autism Spectrum Disorder (ASD). The study will specifically investigate whether participants can learn to deliver PRT effectively following participation in the Online training.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
44 (estimated)
First submitted
15 Jul 2024
Start date
30 Jan 2026
Primary completion date
30 Dec 2028
Lead sponsor
Stanford University
Diseases
Autism
NCT number
NCT06523387

What you commit to

  • Study type: Interventional
  • Planned participants: 44
  • From 30 Jan 2026 to the primary completion date, 30 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • previous adequate trial of pivotal response treatment resulting in parent meeting Pivotal Response Treatment fidelity of implementation at baseline
  • Receiving more than 15 hours of in home 1:1 ABA per week

Other illness

  • parent or child diagnosed with severe psychiatric disorder or unstable medical problem

Other

  • Children who have a primary language other than English
  • living within 100 miles of Stanford University.

Who the study is looking for

  • 2:0 to 5:11 years at the time of consent,
  • diagnosed with ASD (based on history, review of available medical records including diagnostic testing, e.g., Autism Diagnostic Observation Schedule) or suspicion of Autism Spectrum Disorder diagnosis, and confirmed with Autism Diagnostic Interview-Revised (ADI-R),
  • with significant adaptive communication deficits (i.e., either a Vineland-3 Communication subscale 2 Standard Deviations below average for 2 and 3 year olds and 3 Standard Deviations below for 4 and 5 year olds or a Vineland-3 Expressive V-scale Score 2 Standard Deviations below average for 2 and 3 year olds, or 3 Standard Deviations below for 4 and 5 year old, and at least moderate severity on the Clinical Global Impressions Severity (CGI-S) language subscale),
  • an English-speaking parent able to consistently participate in study procedures and conduct treatment in English,
  • stable psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation,
  • stable treatment (ABA, Floortime, or other interventions), speech therapy, and school placement for at least 1 month prior to baseline measurements with no expected changes during study participation,
  • no more than 60 minutes of 1:1 speech therapy per week

Age in the registry: 2 years to 5 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Stanford University
Coordinator of this site? Confirm its status
StanfordUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.